All the above results showed that Spautin-1 arrested DLBCL cell survival without affecting normal lymphocytes, and synergized with Dox or CTX, possibly due to intervention with Notch and NF-κB. The gene discussed is NFKB1; the disease is diffuse large B-cell lymphoma.